Luye Pharma AG
PolandAll drugs from this manufacturer
-
Atmina is used in adult patients with mild to moderately severe Alzheimer's-type dementia to alleviate the symptoms of this disease.
Dosage form: plaster, transdermal system
Active substance Dosage rivastigmine 4.6 mg/24 h ATC: N06DA03
-
The medicine is intended for adult patients with Alzheimer's-type dementia of mild to moderately severe severity.
Dosage form: plaster, transdermal system
Active substance Dosage rivastigmine 9.5 mg/24 h ATC: N06DA03
-
The medicine is intended for adult patients with mild to moderately severe Alzheimer's-type dementia, which causes problems with memory, behavior, and intellectual abilities.
Dosage form: plaster, transdermal system
Active substance Dosage rivastigmine 6.9 mg ATC: N06DA03
-
The medicine is used in adult patients with mild to moderately severe Alzheimer's-type dementia, which causes impairments in memory, intellectual abilities, and behavior.
Dosage form: plaster, transdermal system
Active substance Dosage rivastigmine 13.8 mg ATC: N06DA03